LifeStance Health (LFST) Acquisitions (2020 - 2026)

LifeStance Health has disclosed Acquisitions across 5 years of filings, most recently posting $3.1 million for Q1 2026.

• In Q1 2026, Acquisitions changed N/A year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2023 annual figure was $19.8 million, down 67.08% from the prior year.
• Acquisitions retreated to $3.1 million in Q1 2026, from $19.8 million in the prior quarter.
• Over the last five years, Acquisitions for LFST reached as high as $22.9 million in Q1 2022 and fell as low as $3.1 million in Q1 2026.
• The 3-year median for Acquisitions is $16.0 million (2022), against an average of $13.9 million.
• The widest YoY moves for Acquisitions: up 2943.1% in 2022, down 51.3% in 2022.
• A 3-year view of Acquisitions shows it stood at $19.9 million in 2022, then decreased by 0.46% to $19.8 million in 2023, then slumped by 84.14% to $3.1 million in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $3.1 million, $19.8 million, and $19.9 million for Q1 2026, Q1 2023, and Q4 2022 respectively.